Access cutting-edge cancer treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access cancer specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
This is a Phase 1/2, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX0902 alone and in combination with MRTX849 (adagrasib) in patients with advanced solid tumor malignancy harboring mutations in the KRAS-MAPK pathways.
Sponsor: Mirati Therapeutics Inc.
Check if you qualify for this cancer clinical trial in Orlando, FL
If you're searching for cancer treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.